TLRY - Tilray Brands • Financials

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
12/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2023	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2024	789	-48	-	L	L	3,443	L	45	L	-63	-29	-75	-92	0	0	-	0%
05/2025	821	-2,149	-	L	L	1,511	L	-14	-	-119	-33	134	-152	0	-2	L	0.41%
05/2026	915	5	-	L	L	1,614	L	-23	-	-115	-34	131	-149	0	0	-	0%

To see all financials—including updated, you must be Premium.